Minh-Hong Nguyen
Infectious Disease · Pittsburgh, PANPI 1760419436
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $16,688 of the $20,403 with a category attached, or 81.8%. 7 manufacturers reported payments, led by Astellas Pharma Global Development at 50.8% of the total. Among infectious disease clinicians in PA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 21 payments — averaging $971.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma Global Development$10K
- Shionogi Inc$5K
- Abbott$3K
- Mayne Pharma Commercial LLC$2K
- Scynexis, Inc.$93
- Melinta Therapeutics, LLC$65
- plus $28 from 1 others
Across 300 payments — averaging $4482.93 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Merck$634K
- Biomerieux Inc$290K
- Astellas Pharma Global Development$285K
- Melinta Therapeutics, LLC$100K
- Scynexis, Inc.$19K
- Mayne Pharma Commercial LLC$17K
What the payments were for
- Consulting fees$16,68882%
- Speaking & faculty fees$2,00010%
- Travel & lodging$2601%
- Food & beverage$1,4557%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma Global Development | 4 | $10,358 |
| Shionogi Inc | 7 | $5,192 |
| Abbott | 4 | $2,635 |
| Mayne Pharma Commercial LLC | 2 | $2,032 |
| Scynexis, Inc. | 2 | $93 |
| Melinta Therapeutics, LLC | 1 | $65 |
| GSK | 1 | $28 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CRESEMBA$10,358
- Fetroja$5,000
- ID NOW INSTRUMENT$2,550
- TOLSURA$2,000
How this compares
$20,403 in reported general payments places this provider in the 90th percentile of 457 infectious disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other infectious disease in Pittsburgh
- Amesh AdaljaPittsburgh$415K
- Micah JacobsPittsburgh$206K
- Brandon SmithPittsburgh$108K
- Lee HarrisonPittsburgh$70K
- Yohei DoiPittsburgh$67K
- Chiu Bin HsiaoPittsburgh$33K
- Ghady HaidarPittsburgh$19K
- Thomas WalshPittsburgh$10K
- Fernanda SilveiraPittsburgh$7K
- Stacy LanePittsburgh$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.